IL17A and chronic rhinosinusitis without nasal polyps: The results indicate that IL-17A may play a significant role in the LRRK2 signaling pathway in CRSsNP patients, while both Th1 and Th2 cytokines participate in the inflammation activities of CRSsNP nasal mucosa.